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Glycogen Storage Disease Type Ia: Adult
Presentation With Microcytic Anemia
and Liver Adenomas
Wouter Moest,1 Wendy van der Deure,1 Ted Koster,1 Marcela Spee-Dropkova,2 Linda Swart-Busscher,3
Robbert J. de Haas,4 and Terry G.J. Derks 5
Glycogen storage disease type Ia (GSD Ia;OMIM #232200) is an ultra-rare inheritedmetabolic disorder caused by deﬁcient
glucose-6-phosphatase (G6Pase; EC 3.1.3.9) activity,
which hydrolyzes glucose-6-phosphate (G6P), to pro-
duce glucose in the endoplasmic reticulum lumen in
the ﬁnal common pathway of glycogenolysis and glu-
coneogenesis. Classically, symptoms and signs in
the ﬁrst year of life include severe fasting intolerance,
failure to thrive, and hepatomegaly, biochemically
characterized by nonketotic hypoglycemia, fasting
hyperlactidemia, hyperuricaemia, and hyperlipidaemia
(Fig. 1),(1) but few milder phenotypes are described.(2)
Dietary management is the cornerstone of treatment
aiming at maintenance of euglycemia, prevention of
secondary metabolic perturbations, and long-term
complications including the liver (hepatocellular ade-
nomas and carcinomas).(1)
Case Report
A 25-year-old woman presented with acute abdomi-
nal pain in the right upper quadrant and fever at the
emergency department of a local hospital in January
2017. Laboratory tests displayed hypoglycemia (glu-
cose 2.5 mmol/L), hyperlactatemia (lactate 9.1 mmol/
L), and hyperlipidemia (triglycerides 10.6 mmol/L,
cholesterol 6.1 mmol/L), without urinary ketones. She
was treated with an intravenous bolus of 100 mL of
glucose 10%, subsequent 125-mL/h maintenance infu-
sion of sodium chloride 0.45% and glucose 5.0%, and
antibiotics under the working diagnosis of a sepsis
with an abdominal focus. Symptoms recovered quickly,
but glucose concentrations remained relatively low.
At that time, medical history revealed that she had
been referred by the general practitioner in September
2016 because of fatigue, weight loss, nocturnal sweat-
ing, hypermenorrhea, and nose bleedings, associated
with microcytic anemia (hemoglobin 4.5 mmol/L;
mean corpuscular volume 59 fL). Abdominal imaging
(December 2016) displayed hepatomegaly with multi-
ple hepatocellular adenomas (Fig. 2A), based on
which, the radiologist reported a suspicion of glycogen
storage disease. After referral to the center of expertise,
the working diagnosis of GSD Ia was established.
Our patient is the child of ﬁrst-degree cousins of
Moroccan ancestry and had hospital admissions in
childhood due to various infections. Since 1993, our
patient had suffered tiredness, for which she was fol-
lowed by the local pediatrician. Between 2000 and
2006, she was evaluated by the pediatric immunologist
and gastroenterologist because of failure to thrive,
hepatomegaly, and persisting increase of erythrocyte
sedimentation rate. She was growing at –2.5 SDs,
below her target range, with delayed bone age, and
Abbreviations: G6P, glucose-6-phosphatase; G6Pase, glucose-6-phosphatase; GSD Ia, glycogen storage disease type Ia.
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increased plasma uric acid concentrations were not rec-
ognized. She reported obvious signs of fasting intoler-
ance; during the day, she frequently drank juices, and
during the nights, she was hungry, sweating, and woke
at least 1-2 times to eat or drink carbohydrate-
containing substances. She got married in March 2016
and was working a full-time job as an elementary
school teacher.
Dietary management was started with restrictions of
sucrose, fructose, and lactose and frequent, small doses
of uncooked cornstarch, ﬁnally reaching 40 g every 4
hours, day and night. She was advised to discontinue
her estrogen-containing oral contraceptive (that she
had been using since March 2016) and to use alterna-
tive contraception. After 5 weeks, nocturnal cornstarch
management was changed toward 120 g of extended-
release cornstarch for 8 hours of sleep.
Regarding the liver adenomas, we aimed at a conser-
vative, nonsurgical management and repeating liver
imaging to evaluate the effect of the discontinuation
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FIG. 1. The effect of liver (gray) G6Pase deﬁciency on major pathways of endogenous glucose production (glycogenolysis and gluco-
neogenesis), ketogenesis, and lipogenesis during fasting. This simpliﬁed scheme explains the biochemical phenotype of hypo- or non-
ketotic hypoglycemia, hyperlactatecemia, hyperuricemia, and hyperlipidemia. Hepatomegaly is caused by storage of both glycogen and
lipids. To compensate deﬁcient endogenous glucose production, avoidance of fasting and regular meals are prescribed. Uncooked corn-
starch is digested slowly and provides a steady release of exogenous glucose molecules, compared to simple sugars. To prevent noctur-
nal hypoglycemias, either cornstarch-enriched feedings every 3-4 hours (especially for infants, some adult GSD Ia patients may
eventually need only one bedtime dose) are offered, or alternatively continuous gastric drip feeding. Because dietary fructose and galac-
tose cannot be metabolized from G6P toward glucose, they contribute to the metabolic perturbation. Therefore, these dietary sugars
are often restricted or avoided. Abbreviation: Acetyl-CoA, acetyl coenzyme A.
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of oral contraceptive use and the start of dietary man-
agement. As reported,(3) a signiﬁcant decrease in ade-
noma sizes was observed in February 2018 (see legend
Fig. 2). Meanwhile, Sanger sequencing of the G6PC
gene revealed homozygosity for the c.1039C>T
(p.Gln347X) mutation, conﬁrming our working
hypothesis.
Discussion
After the classical textbook phenotype of monoge-
netic disorders, like GSD Ia, the complete clinical and
biochemical spectrum is discovered. GSD Ia is an
ultra-rare, but treatable, inherited metabolic disorder
that can be diagnosed based on detailed history taking,
physical examination, and standard laboratory investi-
gations, even in relatively mildly presenting adult
patients. Basic, but targeted, clinical testing is war-
ranted to exclude GSD Ia in patients presenting atypi-
cal liver adenomas. Rapid diagnosis and proper dietary
treatment are important to prevent symptomatic
hypoglycemias, acute life-threatening metabolic per-
turbations, and chronic complications, related to liver
adenomas and kidney disease.
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FIG. 2. Abdominal MRI image from our patient displaying
hepatomegaly and multiple hepatocellular adenomas. On the
T2-weighted image, many mildly hyperintense lesions are visi-
ble diffusely distributed in all liver segments, with a maximum
diameter of 4.6 cm. The lesions showed arterial enhancement
after administration of intravenous contrast material, persisting
in the portal venous phase, consistent with hepatocellular ade-
nomas (not shown). During the second trimester of her preg-
nancy, follow-up MRI in August 2017 displayed no signiﬁcant
changes compared to the initial MRI. After an uneventful preg-
nancy and Caesarian section in November 2017, follow-up
MRI in February 2018 showed signiﬁcant decrease in adenoma
size, with the largest lesion measuring 4.1 cm (not shown).
Based on the initial MRI and CT images of our patient, an
interactive 3D model was created presenting the hepatomegaly,
hepatocellular adenomas (in blue), and renomegaly in our
patient (https://skfb.ly/6uEvD). Abbreviation: 3D, three-
dimensional; CT, computed tomography; MRI, magnetic reso-
nance imaging.
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